Immunotherapy: Open Access
Open Access

Melanoma Immunotherapy

Immunotherapy for melanoma is used for metastatic melanoma and at high risk of recurrence. Many immunotherapies are been approved by FDA. Melanoma Immunotherapy is broadly categorised into cancer vaccines, monoclonal antibodies, adoptive T-cell therapy, immunomodulators, cytokines and oncolytic virus therapies.

This therapy is widely used and it targets melanoma cells in the body irrespective of location.

Related Journals of Melanoma Immunotherapy

Immunotherapy: Open Access, Immunome Research journal, Immunology Journal, Immunooncology journal, Immunobiology journal, The New England Journal of Medicine, Journal of Immunotherapy of Cancer, Nuero-Oncology, Frontiers in Oncology, Future Oncology.